EUVIMEDEUVIMED entdecken
Crossref

Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia : A consensus statement

MA Shekar, Sanjay Kalra, AH Aamir, Abbas Raza, AK Das, AK Azad Khan, Dina Shrestha, MdFaisal Qureshi, Md Fariduddin, MdFaruque Pathan, Fatema Jawad, Jyoti Bhattarai und 11 weitere

APIK Journal of Internal Medicine · 2016

DOI: 10.4103/2666-1802.258249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift APIK Journal of Internal Medicine, 2016. Verfasst von MA Shekar und 22 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Shekar, M., Kalra, S., Aamir, A., Raza, A., Das, A., Khan, A. A., Shrestha, D., Qureshi, M., Fariduddin, M., Pathan, M., Jawad, F., Bhattarai, J., Tandon, N., Somasundaram, N., Katulanda, P., Sahay, R., Dhungel, S., Bajaj, S., Chowdhury, S., …, & Bulughapitiya, U. (2016). Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia : A consensus statement. APIK Journal of Internal Medicine. https://doi.org/10.4103/2666-1802.258249

Vancouver

Shekar M, Kalra S, Aamir A, Raza A, Das A, Khan AA, et al. Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia : A consensus statement. APIK Journal of Internal Medicine. 2016. doi:10.4103/2666-1802.258249

BibTeX
@article{Shekar2016,
  author = {Shekar, MA and Kalra, Sanjay and Aamir, AH and Raza, Abbas and Das, AK and Khan, AK Azad and Shrestha, Dina and Qureshi, MdFaisal and Fariduddin, Md and Pathan, MdFaruque and Jawad, Fatema and Bhattarai, Jyoti and Tandon, Nikhil and Somasundaram, Noel and Katulanda, Prasad and Sahay, Rakesh and Dhungel, Sanjib and Bajaj, Sarita and Chowdhury, Subhankar and Ghosh, Sujoy and Madhu, SV and Ahmed, Tofail and Bulughapitiya, Uditha},
  title = {Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia : A consensus statement},
  journal = {APIK Journal of Internal Medicine},
  year = {2016},
  doi = {10.4103/2666-1802.258249}
}
Kostenlos starten →